Cargando…

Artificial intelligence quantified tumour-stroma ratio is an independent predictor for overall survival in resectable colorectal cancer

BACKGROUND: An artificial intelligence method could accelerate the clinical implementation of tumour-stroma ratio (TSR), which has prognostic relevance in colorectal cancer (CRC). We, therefore, developed a deep learning model for the fully automated TSR quantification on routine haematoxylin and eo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Ke, Li, Zhenhui, Yao, Su, Wang, Yingyi, Wu, Xiaomei, Xu, Zeyan, Wu, Lin, Huang, Yanqi, Liang, Changhong, Liu, Zaiyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648125/ https://www.ncbi.nlm.nih.gov/pubmed/33039706 http://dx.doi.org/10.1016/j.ebiom.2020.103054

Ejemplares similares

Artificial intelligence for quantifying immune infiltrates interacting with stroma in colorectal cancer
por: Yang, Jing, et al.
Publicado: (2022)

Prognostic value of a modified Immunoscore in patients with stage I−III resectable colon cancer
por: Zhao, Ke, et al.
Publicado: (2021)

A deep learning quantified stroma-immune score to predict survival of patients with stage II–III colorectal cancer
por: Xu, Zeyan, et al.
Publicado: (2021)

The role of artificial intelligence to quantify the tumour-stroma ratio for survival in colorectal cancer
por: Smit, Marloes A, et al.
Publicado: (2020)

The value of the tumour-stroma ratio for predicting neoadjuvant chemoradiotherapy response in locally advanced rectal cancer: a case control study
por: Liang, Yanting, et al.
Publicado: (2021)

Deep learning quantified mucus-tumor ratio predicting survival of patients with colorectal cancer using whole-slide images
por: Zhao, Ke, et al.
Publicado: (2021)

Artificial intelligence for quantifying Crohn’s-like lymphoid reaction and tumor-infiltrating lymphocytes in colorectal cancer
por: Xu, Yao, et al.
Publicado: (2022)

Development and Validation of an Immune-Based Prognostic Risk Score for Patients With Resected Non-Small Cell Lung Cancer
por: He, Lan, et al.
Publicado: (2022)

Spleen Radiomics Signature: A Potential Biomarker for Prediction of Early and Late Recurrences of Hepatocellular Carcinoma After Resection
por: Li, Pinxiong, et al.
Publicado: (2021)

Tumour budding and tumour–stroma ratio in hepatocellular carcinoma
por: Kairaluoma, Valtteri, et al.
Publicado: (2020)

Hist-Immune signature: a prognostic factor in colorectal cancer using immunohistochemical slide image analysis
por: Zhao, Ke, et al.
Publicado: (2020)

Machine Learning Quantified Tumor-Stroma Ratio Is an Independent Prognosticator in Muscle-Invasive Bladder Cancer
por: Zheng, Qingyuan, et al.
Publicado: (2023)

Coupling radiomics analysis of CT image with diversification of tumor ecosystem: A new insight to overall survival in stage I−III colorectal cancer
por: Huang, Yanqi, et al.
Publicado: (2022)

Tumour-stroma ratio and prognosis in gastric adenocarcinoma
por: Kemi, Niko, et al.
Publicado: (2018)

Artificial intelligence-assisted analysis for tumor-immune interaction within the invasive margin of colorectal cancer
por: Ye, Yunrui, et al.
Publicado: (2023)

The prognostic significance of tumour-stroma ratio in endometrial carcinoma
por: Panayiotou, Hannah, et al.
Publicado: (2015)

A radiomics prognostic scoring system for predicting progression-free survival in patients with stage IV non-small cell lung cancer treated with platinum-based chemotherapy
por: He, Lan, et al.
Publicado: (2021)

Prognostic significance of tumour stroma ratio in inflammatory breast cancer
por: Downey, Candice L, et al.
Publicado: (2015)

Gastric cancer nodal tumour–stroma ratios influence prognosis
por: Huang, J., et al.
Publicado: (2020)

Radiomics-based predictive risk score: A scoring system for preoperatively predicting risk of lymph node metastasis in patients with resectable non-small cell lung cancer
por: He, Lan, et al.
Publicado: (2019)

Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?
por: Eriksen, Ann C., et al.
Publicado: (2018)

Automated whole-slide images assessment of immune infiltration in resected non-small-cell lung cancer: towards better risk-stratification
por: Lin, Huan, et al.
Publicado: (2022)

MR diffusion-weighted imaging-based subcutaneous tumour volumetry in a xenografted nude mouse model using 3D Slicer: an accurate and repeatable method
por: Ma, Zelan, et al.
Publicado: (2015)

Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study
por: Smit, Marloes A., et al.
Publicado: (2021)

The prognostic significance of tumour–stroma ratio in oestrogen receptor-positive breast cancer
por: Downey, C L, et al.
Publicado: (2014)

Hypoxic Signalling in Tumour Stroma
por: Laitala, Anu, et al.
Publicado: (2018)

Reponse to: comment on, ‘Tumour-stroma ratio (TSR) in oestrogen-positive breast cancer patients'
por: Downey, C L, et al.
Publicado: (2015)

Comment on: The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer
por: Mesker, W E, et al.
Publicado: (2015)

Evaluation of human epidermal growth factor receptor 2 status of breast cancer using preoperative multidetector computed tomography with deep learning and handcrafted radiomics features
por: Yang, Xiaojun, et al.
Publicado: (2020)

Predicting treatment response to neoadjuvant chemoradiotherapy in local advanced rectal cancer by biopsy digital pathology image features
por: Zhang, Fang, et al.
Publicado: (2020)

Computerized tumor-infiltrating lymphocytes density score predicts survival of patients with resectable lung adenocarcinoma
por: Pan, Xipeng, et al.
Publicado: (2022)

Quantifying heterogeneity to drug response in cancer–stroma kinetics
por: Alemanno, Francesco, et al.
Publicado: (2023)

The prognostic value of tumour–stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review
por: Kramer, C. J. H., et al.
Publicado: (2018)

Multi-scale pathology image texture signature is a prognostic factor for resectable lung adenocarcinoma: a multi-center, retrospective study
por: Wang, Yumeng, et al.
Publicado: (2022)

Preoperative lymphocyte-to-monocyte ratio (LMR) could independently predict overall survival of resectable gastric cancer patients
por: Pan, Yu-Chen, et al.
Publicado: (2018)

The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study
por: Eriksen, Ann Christina, et al.
Publicado: (2018)

Artificial intelligence method to predict overall survival of hepatocellular carcinoma
por: Simsek, Cem, et al.
Publicado: (2021)

Tumour-stroma ratio and 5-year mortality in gastric adenocarcinoma: a systematic review and meta-analysis
por: Kemi, Niko, et al.
Publicado: (2019)

Tumour stroma ratio is a potential predictor for 5-year disease-free survival in breast cancer
por: Yan, Dandan, et al.
Publicado: (2022)

Epigenetic Mechanisms beyond Tumour–Stroma Crosstalk
por: Gagliano, Teresa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_83ph49dduaik0v8b70q60l9huj